OTP Exclusive: Lilly Has Been Quietly Exploring Alternative Avenues to Shut Down Tirzepatide Compounding Dave Knapp Oct 25, 2024 4 min read In an exclusive interview last night with Scott Brunner, CEO of the Alliance for Pharmacy Compounding , we uncovered a bombshell: Eli Lilly has been working quietly but diligently on additional means to remove compounded versions of tirzepatidethe active ingredient in Mounjaro and Zepboundfrom the U.S
Trulicity is a different drug, dulaglutide, used to treat diabetes in adults and children ages 10 and older
The CDC confirms that alcohol consumption combined with heat exposure significantly elevates dehydration and heat illness risk
How to manage heart failure with preserved ejection fraction: practical guidance for clinicians
The telehealth visit is short, the pricing is transparent, and the medication shows up at your door
Which Tests Might A Clinician Order To Find A Cause